Arterial complications of migraine treatment with methysergide and parenteral ergotamine.
D000328:Adult; D001157:Arterial Occlusive Diseases / Q000139:chemically induced*; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008784:Methysergide / Q000009:adverse effects*; D008881:Migraine Disorders / Q000188:drug therapy*
D004878:Ergotamine; D008784:Methysergide